Abstract:Background: Haemochromatosis is a genetic disease characterized by the excessive deposition of iron in various tissues and organs, eventually results in organ damage including cirrhosis, diabetes, cardiomyopathy, etc. SLC40A1-related haemochromatosis is associated with gain-of-function mutations in the SLC40A1 gene, which encodes ferroportin. While sporadic reports of this condition exist in mainland China, the understanding of the phenotype and genetic pattern associated with the SLC40A1 p.Y333H mutation remains incomplete. Case presentation: We report a pedigree with heterozygous p.Y333H mutation in Chinese Han population. The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation. He displayed markedly elevated serum ferritin level and transferrin saturation. Magnetic resonance imaging showed iron deposition in the liver, spleen, and pancreas, along with cirrhosis and splenomegaly. Whole exome sequencing identified a heterozygous allelic variant c.997T > C (p.Y333H). Genetic screening of family members identified four first-degree relatives and three second-degree relatives having the same mutation. Additional cases with this mutation from two published studies were included. Among the probands and screened relatives, all eight males aged over 30 y had ferritin level > 1000 µg/L, transferrin saturation > 90%. Four patients with organ damage in the present study received therapeutic phlebotomy, alleviating clinical symptoms and improving in transferrin saturation and serum ferritin. Conclusions: This study reports the largest pedigree with heterozygous SLC40A1 p.Y333H mutation in the Chinese population to date. In Chinese families, males over 30 years old with hemochromatosis due to SLC40A1 p.Y333H mutation exhibit severe iron overload phenotypes.

Severe Myocardial Dysfunction Reversed by Iron-Chelation Therapy in an Asian Patient with Hereditary Hemochromatosis.

Iron Chelators Reverse Organ Damage in Type 4B Hereditary Hemochromatosis Case Reports

Iron Overload Cardiomyopathy due to Non-Classical Hereditary Hemochromatosis

[Chinese guidelines for the diagnosis and treatment of hereditary hemochromatosis]

Genetic diagnosis of hereditary hemochromatosis

SLC40A1-related hemochromatosis associated with a p.Y333H mutation in mainland China: a pedigree report and literature review

210 DECITABINE TREATMENT COULD AMELIORATE PRIMARY IRON-OVERLOAD IN MYELODYSPLASTIC SYNDROME PATIENTS

Advances in pathophysiology, diagnosis and management of hereditary hemochromatosis

S4408 Iron Overload: A Case of Hidden Hemochromatosis

Case report: A rare case of hereditary hemochromatosis caused by a mutation in the HAMP gene in Fuyang, China

Late-onset Hemochromatosis: Co-inheritance of β-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations

Sudden Onset Iron Overload Cardiomyopathy After Liver Transplantation

Hereditary hemochromatosis: a case report and review of the literature

Hemochromatosis—How Not to Overlook and Properly Manage "Iron People"—A Review

High-output cardiac failure in the setting of iron deficiency anaemia: a case report

Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications

Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators' era

Improvement of Chronic Hepatitis B by Iron Chelation Therapy in a Patient with Iron Overload

Diagnosis and Management of Genetic Iron Overload Disorders

Mitochondrial Dysfunction May Explain the Cardiomyopathy of Chronic Iron Overload.

From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease